| 08:30 | P3601 | Association of cdkn2b rs2891168 polymorphism with wall motion index score and the development of major adverse cardiovascular events within one year following st elevation myocardial infarction. | Ferida MAGAMEDKERIMOVA (Kazan, Russian Federation) |
|
| 08:30 | P3603 | Impact of idiopathic thrombocytopenic purpura on clinical outcomes in patients with acute myocardial infarction | Omar CHEHAB (London, United Kingdom of Great Britain & Northern Ireland) |
|
| 08:30 | P3604 | Gender difference in Low-BMI patients with acute myocardial infarction makes an impact on mid-term outcomes | Goro YOSHIOKA (Miyazaki, Japan) |
|
| 08:30 | P3605 | Lower benefit of women than men with ST-elevation myocardial infarction networks system in Spain: a study of 325,017 episodes over 10 years (2005-2015) | Antonia SAMBOLA AYALA (Barcelona, Spain) |
|
| 08:30 | P3606 | Impact of diabetes mellitus on the selection of antiplatelet treatment and medium-term prognosis after acute coronary syndrome | Laura NUNEZ MARTINEZ (Cuenca, Spain) |
|
| 08:30 | P3607 | Temporal trends in the characteristics, management, and clinical outcomes of patients with prior myocardial infarction who are admitted with an acute coronary syndrome | Alon EISEN (Petah Tikva, Israel) |
|
| 08:30 | P3608 | Long-term mortality and mode of death among patients with type 1 and 2 myocardial infarction. | Yader SANDOVAL (Minneapolis, United States of America) |
|
| 08:30 | P3609 | Temporal trends of the management and outcomes of patients after myocardial infarction according to the risk for recurrent cardiovascular events | Tzlil GRINBERG (Petah Tikva, Israel) |
|
| 08:30 | P3610 | Prognostic implication of new-onset atrial fibrillation burden in patients with acute myocardial infarction | Jiachen LUO (Shanghai, China) |
|
| 08:30 | P3611 | The effect of concomitant AF on in-hospital clinical outcomes of NSTE-ACS related hospitalizations in the United States: an analysis of rates, trends and predictors from 2004 to 2014. | Mohamed MOHAMED (Birmingham, United Kingdom of Great Britain & Northern Ireland) |
|
| 08:30 | P3612 | Validation of Charlson Comorbidity Index to predict adverse events in elderly patients with Atrial Fibrillation and Acute Coronary Syndrome: an analysis from LONGEVO-SCA Registry. | Maria Asuncion ESTEVE PASTOR (Elche - Alicante, Spain) |
|
| 08:30 | P3613 | J-shaped relationship between cardiac mortality risk and admission systolic blood pressure in patients aged 65 years and over with acute coronary syndrome | Chunyan JIANG (Beijing, China) |
|
| 08:30 | P3614 | Impact of renal dysfunction in patients with acute myocardial infarction on early management and outcome: a first observational french study | Virginie BERNARD (Lyon, France) |
|
| 08:30 | P3615 | The number of coronary risk factors and mortality in patients with acute myocardial infarction from japanese nation-wide real-world database | Hiroyoshi MORI (Yokohama, Japan) |
|
| 08:30 | P3617 | Systolic blood pressure, glycemic control and clinical outcome in diabetic patients with acute myocardial infarction | Yoon Jung PARK (, Korea (Republic of)) |
|
| 08:30 | P3618 | Underweight predicts greater risk of cardiac mortality post acute myocardial infarction | Wen SU (Beijing, China) |
|
| 08:30 | P3619 | incidence of progressively reduced LVEF during long-year follow-up after myocardial infarction : impact for mid-term outcomes | Goro YOSHIOKA (Miyazaki, Japan) |
|
| 08:30 | P3620 | How does diabetes mellitus influence prognosis of patients with acute myocardial infarction treated with primary angioplasty and potent p2y12 inhibitors. | Stanislav SIMEK (Prague, Czechia) |
|
| 08:30 | P3621 | Epidemiology of acute coronary syndrome by subtype in New Zealand 2006-2016: an ANZACS-QI nationwide linkage study of hospitalisation, procedures and case fatality. | Tom Kai Ming WANG (Auckland, New Zealand) |
|
| 08:30 | P3622 | Demographic and clinical characteristics of atrial fibrillation patients suffering from an ACS without prior revascularization history | Oner OZDOGAN (Izmir, Turkey) |
|